ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 147 filers reported holding ASCENDIS PHARMA A/S in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $772,000 | +63.6% | 5,000 | +19.2% | 0.21% | +18.3% |
| Q1 2020 | $472,000 | -32.2% | 4,195 | -16.1% | 0.18% | +63.6% |
| Q4 2019 | $696,000 | -27.7% | 5,000 | -50.0% | 0.11% | -20.1% |
| Q3 2019 | $963,000 | -16.4% | 10,000 | 0.0% | 0.13% | 0.0% |
| Q2 2019 | $1,152,000 | -2.1% | 10,000 | 0.0% | 0.13% | +38.1% |
| Q1 2019 | $1,177,000 | +87.7% | 10,000 | 0.0% | 0.10% | +83.0% |
| Q4 2018 | $627,000 | -11.6% | 10,000 | 0.0% | 0.05% | +17.8% |
| Q3 2018 | $709,000 | +6.6% | 10,000 | 0.0% | 0.04% | +4.7% |
| Q2 2018 | $665,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |